Lowering mortality in ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: key prehospital and emergency room treatment strategies

被引:9
作者
Goldstein, Patrick [1 ]
Lapostolle, Frederic [2 ]
Steg, Gabriel [3 ]
Danchin, Nicolas [4 ]
Assez, Nathalie
Montalescot, Gilles [5 ]
Charpentier, Sandrine [7 ]
Wiel, Eric
Juliard, Jean Michel [6 ]
机构
[1] CHRU Lille, SAMU Reg Lille, Lille Univ Hosp France, SAMU Nord Emergency Dept, F-59037 Lille, France
[2] Hop Avicenne, EA 3409, SAMU 93, F-93009 Bobigny, France
[3] Univ Paris 07, INSERM, U698, AP HP,Ctr Hosp Bichat Claude Bernard, F-75221 Paris 05, France
[4] HEGP, AP HP, Paris, France
[5] Grp Hosp Pitie Salpetriere, Bur 2 236, Inst Cardiol, F-75634 Paris, France
[6] Hop Bichat Claude Bernard, Dept Cardiol, F-75877 Paris, France
[7] Purpan Univ Hosp, Toulouse Univ Hosp, Serv Aide Med Urgente, Toulouse, France
关键词
acute coronary syndromes; ambulance treatment; antiplatelets; emergency care; myocardial infarction; reperfusion; PERCUTANEOUS CORONARY INTERVENTION; GLYCOPROTEIN IIB/IIIA INHIBITION; MOLECULAR-WEIGHT HEPARIN; TISSUE-PLASMINOGEN-ACTIVATOR; FRONT-LOADED ALTEPLASE; FIBRINOLYTIC THERAPY; REPERFUSION THERAPY; UNFRACTIONATED HEPARIN; THROMBOLYTIC THERAPY; PRIMARY ANGIOPLASTY;
D O I
10.1097/MEJ.0b013e328329794e
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Achieving optimal outcomes in patients with acute coronary syndromes depends on early reperfusion supported by rapid initiation of adjunctive antiplatelet and anticoagulant therapy. The use of the ambulance setting to initiate treatment provides an opportunity to dramatically reduce the time between symptom onset and reperfusion, and a growing body of evidence shows that prehospital reperfusion therapy is associated with significantly better short-term and long-term outcomes than in-hospital administration of the same treatment. In patients with ST-segment elevation myocardial infarction, fibrinolysis must be supported by optimal antiplatelet therapy. Recent studies have shown that, compared with aspirin monotherapy, treatment with a combination of aspirin and clopidogrel significantly improves outcome. The majority of these patients should also receive heparin (unfractionated or low molecular weight). The experience of several European emergency response systems initiating prehospital treatment, shows that this strategy is highly effective in improving outcomes for patients with acute coronary syndromes. European Journal of Emergency Medicine 16:244-255 (c) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:244 / 255
页数:12
相关论文
共 103 条
[1]  
ABRAHAM J, 2008, J THROMB THROMBOLYSI
[2]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[3]  
American College of Cardiology, 2008, CATHETER CARDIOVASC, V71, pe1, DOI DOI 10.1002/CCD.21475
[4]   A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction [J].
Andersen, HR ;
Nielsen, TT ;
Rasmussen, K ;
Thuesen, L ;
Kelbaek, H ;
Thayssen, P ;
Abildgaard, U ;
Pedersen, F ;
Madsen, JK ;
Grande, P ;
Villadsen, AB ;
Krusell, LR ;
Haghfelt, T ;
Lomholt, P ;
Husted, SE ;
Vigholt, E ;
Kjaergard, HK ;
Mortensen, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) :733-742
[5]  
[Anonymous], 1988, LANCET, V2, P349
[6]  
[Anonymous], 1986, LANCET, V1, P397
[7]  
[Anonymous], AM HEART J
[8]   Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction [J].
Antman, EM ;
Morrow, DA ;
McCabe, CH ;
Murphy, SA ;
Ruda, M ;
Sadowski, Z ;
Budaj, A ;
López-Sendón, JL ;
Guneri, S ;
Jiang, F ;
White, HD ;
Fox, KAA ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14) :1477-1488
[9]   INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS [J].
APPLEBY, P ;
BAIGENT, C ;
COLLINS, R ;
FLATHER, M ;
PARISH, S ;
PETO, R ;
BELL, P ;
HALLS, H ;
MEAD, G ;
DIAZ, R ;
PAOLASSO, E ;
PAVIOTTI, C ;
ROMERO, G ;
CAMPBELL, T ;
OROURKE, MF ;
THOMPSON, P ;
LESAFFRE, E ;
VANDEWERF, F ;
VERSTRAETE, M ;
ARMSTRONG, PW ;
CAIRNS, JA ;
MORAN, C ;
TURPIE, AG ;
YUSUF, S ;
GRANDE, P ;
HEIKKILA, J ;
KALA, R ;
BASSAND, JP ;
BOISSEL, JP ;
BROCHIER, M ;
LEIZOROVICZ, A ;
BRUGGEMANN, T ;
KARSCH, KR ;
KASPER, W ;
LAMMERTS, D ;
NEUHAUS, KL ;
MEYER, J ;
SCHRODER, R ;
VONESSEN, R ;
SARAN, RK ;
ARDISSINO, D ;
BONADUCE, D ;
BRUNELLI, C ;
CERNIGLIARO, C ;
FORESTI, A ;
FRANZOSI, MG ;
GUIDUCCI, D ;
MAGGIONI, A ;
MAGNANI, B ;
MATTIOLI, G .
LANCET, 1994, 343 (8893) :311-322
[10]   Assessment of early administration of abciximab in acute ST-segment elevation myocardial infarction in the emergency room [J].
Arhan, A ;
Ecollan, P ;
Madonna-Py, M ;
Kergueno, J ;
Bennaceur, M ;
Josse, MO ;
Montalescot, G ;
Riou, B .
PRESSE MEDICALE, 2006, 35 (01) :45-50